Elizabeth Buck
Founder bij BLACK DIAMOND THERAPEUTICS, INC.
Vermogen: 482 623 $ op 31-03-2024
Profiel
Elizabeth Buck is the founder and currently holds the position of CSO, EVP-Discovery & Translational Sciences at Black Diamond Therapeutics, Inc., which was founded in 2014.
Prior to her current role, she held the position of Assistant Director-Advanced Preclinical at OSI Pharmaceuticals, Inc. from 2005 to 2013.
She also served as the Chief Scientific Officer-Therapeutics at MetaStat, Inc. from 2013 to 2014.
Dr. Buck completed her undergraduate degree at the University of New Hampshire and obtained a doctorate degree from the Icahn School of Medicine at Mount Sinai.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-02-2024 | 95 192 ( 0.18% ) | 482 623 $ | 31-03-2024 |
Actieve functies van Elizabeth Buck
| Bedrijven | Functie | Begin |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Founder | 01-01-2014 |
Eerdere bekende functies van Elizabeth Buck
| Bedrijven | Functie | Einde |
|---|---|---|
| METASTAT, INC. | Chief Tech/Sci/R&D Officer | 01-12-2014 |
Opleiding van Elizabeth Buck
| University of New Hampshire | Undergraduate Degree |
| Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| METASTAT, INC. | Producer Manufacturing |
| BLACK DIAMOND THERAPEUTICS, INC. | Health Technology |
